What is the primary financial performance trend shown in this filing?

This filing provides the unaudited financial statements for the nine months ended March 25, 2007. Investors should examine the Condensed Consolidated Statements of Operations to understand revenue growth or contraction and profitability trends during this period, comparing it against the same period in the prior fiscal year (ended March 26, 2006) for a comprehensive view.

What are the key financial health indicators I should look for in the balance sheet?

Investors should review the Condensed Consolidated Balance Sheets as of March 25, 2007. Key indicators to observe include the levels of cash and equivalents, accounts receivable, inventory, total assets, total liabilities, and shareholders' equity to assess the company's liquidity, solvency, and overall financial strength.

Where can I find information about the risks facing Lam Research Corporation?

Item 1A, 'Risk Factors,' within Part II of this 10-Q filing is dedicated to outlining the potential risks and uncertainties that could materially affect Lam Research Corporation's business, financial condition, or results of operations. Investors should carefully review this section.

Does this filing provide information on cash generation and usage?

Yes, the filing includes the Condensed Consolidated Statements of Cash Flows for the nine months ended March 25, 2007. This statement will detail the company's cash generated from operating, investing, and financing activities, offering insights into how the company is managing its cash resources.

LRCX 10-Q Quarterly Report Q3 FY2007 — Revenue, Net Income, EPS

Summary

Lam Research Corporation's (LRCX) 10-Q filing for the period ending March 25, 2007, reveals a company navigating its financial performance within the semiconductor equipment sector. Investors should note the unaudited condensed consolidated financial statements, which provide a snapshot of the company's assets, liabilities, and equity, as well as its revenue and profitability trends over the first nine months of fiscal year 2007 compared to the prior year. The Management's Discussion and Analysis (MD&A) section is crucial for understanding the drivers behind these financial results, including operational performance, market conditions, and any significant events or risks impacting the company.

Key Highlights

1The filing includes unaudited condensed consolidated financial statements for the balance sheet as of March 25, 2007, and the statements of operations and cash flows for the three and nine months ended March 25, 2007.
2Investors can analyze revenue and profitability trends by comparing the nine-month periods ended March 25, 2007, and March 26, 2006.
3Management's Discussion and Analysis (MD&A) will offer insights into the financial condition, results of operations, and key factors influencing the company's performance.
4The report details quantitative and qualitative disclosures about market risk, which is important for understanding potential impacts from economic fluctuations or industry-specific challenges.
5Risk Factors are disclosed, providing investors with a view of potential challenges and uncertainties the company faces.
6Information on legal proceedings is included, though typically significant developments would be highlighted if they materially impact the company.

LAM RESEARCH CORP Quarterly Report for Q3 Ended Mar 25, 2007

Summary

Key Highlights

Frequently Asked Questions